Jennifer Andrews
Pediatrics · Kansas City, MONPI 1073786349
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 130 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $559 and has fallen 59.0% since, to $229 in 2025. Among pediatrics clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 130 payments — averaging $17.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$417
- GSK$326
- Sobi, Inc$240
- Merck$174
- Supernus Pharmaceuticals, Inc.$139
- Kaleo, Inc.$105
- plus $862 from 20 others
What the payments were for
- Food & beverage$2,262100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 24 | $417 |
| GSK | 23 | $326 |
| Sobi, Inc | 11 | $240 |
| Merck | 11 | $174 |
| Supernus Pharmaceuticals, Inc. | 4 | $139 |
| Kaleo, Inc. | 6 | $105 |
| Sanofi Pasteur Inc. | 7 | $104 |
| Sanofi-aventis U.S. LLC | 3 | $103 |
| Pfizer | 7 | $102 |
| AstraZeneca | 4 | $69 |
| Tris Pharma Inc | 4 | $67 |
| Ironshore Pharmaceuticals Inc. | 3 | $46 |
| Seqirus USA Inc | 2 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $46 |
| Novartis | 2 | $40 |
| Adlon Therapeutics L.p. | 3 | $40 |
| Cranial Technologies, Inc | 2 | $33 |
| Genentech USA, Inc. | 2 | $25 |
| Biogen | 1 | $22 |
| Mylan Pharmaceuticals Inc. | 2 | $22 |
| Abbott | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
| Neurelis, Inc. | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Shire North American Group Inc | 1 | $16 |
| AbbVie | 1 | $15 |
How this compares
$2,262 in reported general payments places this provider in the 90th percentile of 1,306 pediatrics providers in Missouri.
Other pediatrics in Kansas City
- Terri LuetjenKansas City$57K
- Sharon HumistonKansas City$41K
- Nikita RajeKansas City$23K
- Natasha BurgertKansas City$20K
- Jodi ShrobaKansas City$14K
- Rebecca FlynnKansas City$11K
- Brenda SnyderKansas City$10K
- Esosa AdahKansas City$8K
- Charles MoylanKansas City$5K
- Jordan JonesKansas City$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.